Comparison of critical drug-drug interaction listings

The department of veterans affairs medical system and standard reference compendia

E. L. Olvey, S. Clauschee, Daniel C Malone

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

The objective of this study was to evaluate the agreement among the US Department of Veterans Affairs (VA) listing of criticaĺ drug-drug interactions (DDIs) and two standard drug-interaction compendia. A list of critical DDIs, as defined by the VA, was compared with two standard commercially available compendia (Micromedex DRUG-REAX and Drug Interactions: Analysis and Management (DIAM)) in order to determine the level of agreement among the systems. Of 982 DDIs classified as critical by the VA, only 136 DDIs (13.7%) were considered critical in all three systems. Our conclusion was that, overall, there is poor agreement among the compendia and the VA system.

Original languageEnglish (US)
Pages (from-to)48-51
Number of pages4
JournalClinical Pharmacology and Therapeutics
Volume87
Issue number1
DOIs
StatePublished - Jan 2010

Fingerprint

Veterans
Drug Interactions
Pharmaceutical Preparations
United States Department of Veterans Affairs

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{1f358c874d5747cc90232d2b6edfdc61,
title = "Comparison of critical drug-drug interaction listings: The department of veterans affairs medical system and standard reference compendia",
abstract = "The objective of this study was to evaluate the agreement among the US Department of Veterans Affairs (VA) listing of criticaĺ drug-drug interactions (DDIs) and two standard drug-interaction compendia. A list of critical DDIs, as defined by the VA, was compared with two standard commercially available compendia (Micromedex DRUG-REAX and Drug Interactions: Analysis and Management (DIAM)) in order to determine the level of agreement among the systems. Of 982 DDIs classified as critical by the VA, only 136 DDIs (13.7{\%}) were considered critical in all three systems. Our conclusion was that, overall, there is poor agreement among the compendia and the VA system.",
author = "Olvey, {E. L.} and S. Clauschee and Malone, {Daniel C}",
year = "2010",
month = "1",
doi = "10.1038/clpt.2009.198",
language = "English (US)",
volume = "87",
pages = "48--51",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Comparison of critical drug-drug interaction listings

T2 - The department of veterans affairs medical system and standard reference compendia

AU - Olvey, E. L.

AU - Clauschee, S.

AU - Malone, Daniel C

PY - 2010/1

Y1 - 2010/1

N2 - The objective of this study was to evaluate the agreement among the US Department of Veterans Affairs (VA) listing of criticaĺ drug-drug interactions (DDIs) and two standard drug-interaction compendia. A list of critical DDIs, as defined by the VA, was compared with two standard commercially available compendia (Micromedex DRUG-REAX and Drug Interactions: Analysis and Management (DIAM)) in order to determine the level of agreement among the systems. Of 982 DDIs classified as critical by the VA, only 136 DDIs (13.7%) were considered critical in all three systems. Our conclusion was that, overall, there is poor agreement among the compendia and the VA system.

AB - The objective of this study was to evaluate the agreement among the US Department of Veterans Affairs (VA) listing of criticaĺ drug-drug interactions (DDIs) and two standard drug-interaction compendia. A list of critical DDIs, as defined by the VA, was compared with two standard commercially available compendia (Micromedex DRUG-REAX and Drug Interactions: Analysis and Management (DIAM)) in order to determine the level of agreement among the systems. Of 982 DDIs classified as critical by the VA, only 136 DDIs (13.7%) were considered critical in all three systems. Our conclusion was that, overall, there is poor agreement among the compendia and the VA system.

UR - http://www.scopus.com/inward/record.url?scp=72849125569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72849125569&partnerID=8YFLogxK

U2 - 10.1038/clpt.2009.198

DO - 10.1038/clpt.2009.198

M3 - Article

VL - 87

SP - 48

EP - 51

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 1

ER -